Invitation to Roche’s virtual event on key hematology data presented at ASH 2021 Dienstag, 16. November 2021 - 10:09

We are pleased to invite investors and analysts to participate in our virtual event on Wednesday,

15 December, 2021, highlighting Roche data presented at the virtual American Society of Hematology (ASH) 63rd Annual Meeting, from 11-14th December.

16:00 – 17:30 CET / 15:00 - 16:30 GMT

10:00 – 11:30 am EST / 7:00 – 8:30 am PST

The webinar will start with a presentation, followed by a Q&A session (live access to the speakers).

Agenda:

Welcome

Karl Mahler, Head of Investor Relations

Hematology franchise overview

Peter Ahnesorg, Franchise Head Hematology

Review of key clinical data presented at ASH: Hemlibra, mosun, glofit, cevostamab

Charles Fuchs, Senior Vice President - Global Head Of Oncology And Hematology Product Development

Presentation of POLARIX data

Franck Morschhauser, MD, PhD, Professor of Hematology, University of Lille; President of LYSA, LYSARC

Q&A

The slides will be available for download at 15:00 CET on the day of the event. > click here

Access to virtual event (pre-registration required)

Please pre-register for our webinar here*.

Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com.

A replay of the event will be available via > ir.roche.com

*privacy notice

Attachment

• 211115_IR_ASH Invitation_en